Reuters – The United States appears poised to heighten scrutiny of Chinese investment in Silicon Valley to better shield sensitive technologies seen as vital to U.S. national security, current and former U.S. officials tell Reuters.
The New York Times – A new lawsuit invokes the plight of a baby born dependent on opioid drugs, as several drug manufacturers are accused of unleashing an epidemic through deceptive marketing about the risks of addiction to painkillers.
The Hill – Seven states controlled by Democratic administrations are formally challenging the Environmental Protection Agency’s (EPA) decision not to further restrict the use of the controversial pesticide chlorpyrifos.
Reuters – The U.S. Congress is working on national self-driving vehicle legislation that could replace state-by state rules and make it easier for automakers to test and deploy the technology, according to senior U.S. House and Senate lawmakers.
Bloomberg – Thousands of Kansas farmers argue that Syngenta AG posed an even bigger threat by failing to prevent its genetically modified corn seed from contaminating U.S. crops, which led to a devastating rejection of imports by Chinese officials.
The Independent – It has been hailed as a cure for cancer and all forms of inherited disease. But scientists have now discovered that a system for editing the genes of living creatures can have a potentially dangerous side-effect – causing unintended mutations.